Skip to main navigation Skip to search Skip to main content

Pyrrolidine-carboxamides and oxadiazoles as potent hNK1 antagonists

  • Jonathan R. Young
  • , Ronsar Eid
  • , Cherilyn Turner
  • , Robert J. DeVita
  • , Marc M. Kurtz
  • , Kwei Lan C. Tsao
  • , Gary G. Chicchi
  • , Alan Wheeldon
  • , Emma Carlson
  • , Sander G. Mills

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

The preparation and structure-activity-relationships of novel pyrrolidine-carboxamides and oxadiazoles are described. Compounds in this series were found to be potent hNK1 antagonists in vitro and efficacious in vivo with minimal interactions with P450 liver enzymes. Oxadiazole analog 22 was determined to have excellent hNK1 binding affinity, functional activity, and a good PD response in vivo.

Original languageEnglish
Pages (from-to)5310-5315
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number19
DOIs
StatePublished - 1 Oct 2007
Externally publishedYes

Keywords

  • NK antagonists
  • Substance P

Fingerprint

Dive into the research topics of 'Pyrrolidine-carboxamides and oxadiazoles as potent hNK1 antagonists'. Together they form a unique fingerprint.

Cite this